Highlight Therapeutics

BO-112

Biodrugs/ Drugs

Solid tumors in patients with liver metastasis from colorectal cancer or gastric/gastro-esophageal junction cancer. Patients with advanced and/or metastatic melanoma.
2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical